Search clinical trials for: Placebo for dapagliflozin
Total 70361 results
-
Damanhour UniversityMenoufia UniversityUnknownCardiomyopathies | Diabete Type 2 | Heart Failure With Reduced Ejection Fraction (HFrEF)
-
University at BuffaloKaleida HealthCompletedAn Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of DapagliflozinType 2 DiabetesUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingHealthy Participants | Atopic Dermatitis PatientsChina
-
ZYUS Life Sciences Inc.Novotech (Australia) Pty Limited; ZYUS Life Sciences Australia Pty LtdCompletedHealthy | OsteoarthritisAustralia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2China, Malaysia, Vietnam
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States
-
The George InstituteUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...RecruitingAcute Kidney InjuryAustralia
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
State University of New York at BuffaloJuvenile Diabetes Research Foundation; University of GlasgowRecruiting
-
Fundación Pública Andaluza para la Investigación...Unknown
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
AstraZenecaCompletedHealthy Subjects in Fasted and Fed StateBrazil
-
Yale UniversityBoehringer IngelheimRecruitingEnd Stage Renal Disease on DialysisUnited States
-
University Hospital TuebingenWithdrawn
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, United Kingdom, Canada, Sweden, Ireland, Argentina, Brazil, Lebanon, Malaysia, Mexico, Italy
-
Theravance BiopharmaCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Oman Ministry of HealthNot yet recruitingObesity | Weight Loss | Effect of Drug | Dapagliflozin Adverse Reaction
-
University of EdinburghAstraZeneca; NHS LothianRecruiting
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India
-
Spero TherapeuticsSimbec ResearchCompletedHealthy VolunteersUnited Kingdom
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Bio-innova Co., LtdNot yet recruiting
-
Hanmi Pharmaceutical Company LimitedCompletedHypertension | Erectile Dysfunction
-
Yooyoung Pharmaceutical Co., Ltd.Active, not recruitingType 2 DiabetesKorea, Republic of
-
AstraZenecaCompletedChronic PainGermany, Sweden, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
Sheba Medical CenterUnknownCoronary Disease With Diabetes MellitusIsrael
-
Eli Lilly and CompanyOPKO Health, Inc.CompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
YangjinPeking University Third HospitalNot yet recruitingPrediabetic State | Impaired Glucose Tolerance | Impaired Fasting GlucoseChina
-
AstraZenecaCompleted
-
University of Maryland, BaltimoreNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitationDiabetes Mellitus, Type 2
-
Saint Luke's Health SystemCompletedHeart FailureUnited States
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Shanghai Zhongshan HospitalActive, not recruiting
-
Dong-A ST Co., Ltd.Completed
-
Vivozon, Inc.CompletedHealthyKorea, Republic of
-
Novartis PharmaceuticalsCompletedA Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)Homozygous Familial HypercholesterolemiaHong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Denmark, Canada, Belgium, China, Italy, Germany, Spain, Netherlands, Hungary, Japan, Norway, Poland, Sweden, Czechia
-
Miulli General HospitalNot yet recruitingHeart Failure | Obesity | Diabetes Mellitus | Atrial FibrillationItaly
-
University of California, San DiegoJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsCompleted
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingLimited-stage Small Cell Lung Cancer (LS-SCLC)China, France, United States, Spain, Taiwan, Korea, Republic of, Turkey, Italy, Netherlands, Georgia, Germany, Belgium, Poland, Romania
-
University Hospital, Basel, SwitzerlandCompletedHyponatremia | SIAD - Syndrome of Inappropriate AntidiuresisSwitzerland
-
Vivozon, Inc.Completed
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Australia, Germany, Canada, France
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 DiabetesTaiwan, United States, Argentina, Canada, Mexico, Puerto Rico, Philippines, India, Peru